title: DNA fingerprinting of 7,12-dimethylbenz[a]anthracene-induced and spontaneous CD-1 mouse liver tumors.
abstract: Determining to what degree chemicals and environmental agents contribute to the development of cancer would be materially enhanced by the ability to distinguish chemically induced tumors from those that arise spontaneously. Using DNA fingerprinting as an assay, we investigated whether somatic DNA rearrangements are more frequent in chemically induced mouse liver tumors than they are in spontaneous mouse liver tumors. Tumors were induced by a single i.p. injection of 12-day old male Crl:CD-1(ICR)BR (CD-1) mice with 20 nmol/g 7,12-dimethylbenz[a]-anthracene and were harvested 9 to 12 months after injection. Spontaneous tumors were obtained from 94- to 98-week old male CD-1 mice. We detected 8 rearrangements in 14 7,12-dimethylbenz[a]anthracene-induced tumors, which corresponds to a high rearrangement frequency of about 2% (of the minisatellite bands examined). Furthermore, 6 of these rearrangements included complete band losses which must have occurred early in tumor development. However, only 2 band changes were observed in 15 spontaneous tumors, and both changes were intensity shifts which may represent rearrangements that occurred later during tumor progression. Histological examination showed that the higher frequency of rearrangements in 7,12-dimethylbenz[a]anthracene-induced tumors versus spontaneous tumors was not related to differences in the degree of tumor progression or malignancy. Our results suggest that DNA fingerprinting may be a valuable assay for differentiating certain chemically induced tumors from spontaneous tumors.
authors.affiliation: Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania 19486.
authors.forename: B J
authors.initials: BJ
authors.lastname: Ledwith
authors.forename: R D
authors.initials: RD
authors.lastname: Storer
authors.forename: S
authors.initials: S
authors.lastname: Prahalada
authors.forename: S
authors.initials: S
authors.lastname: Manam
authors.forename: K R
authors.initials: KR
authors.lastname: Leander
authors.forename: M J
authors.initials: MJ
authors.lastname: van Zwieten
authors.forename: W W
authors.initials: WW
authors.lastname: Nichols
authors.forename: M O
authors.initials: MO
authors.lastname: Bradley
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene; D000236:Adenoma / Q000139:chemically induced / Q000235:genetics; D000818:Animals; D002277:Carcinoma / Q000139:chemically induced / Q000235:genetics; D004273:DNA, Neoplasm / Q000302:isolation & purification*; D004276:DNA, Satellite / Q000302:isolation & purification; D008113:Liver Neoplasms / Q000139:chemically induced / Q000235:genetics*; D008114:Liver Neoplasms, Experimental / Q000235:genetics*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009154:Mutation; D009710:Nucleotide Mapping
chemical_list: D004273:DNA, Neoplasm; D004276:DNA, Satellite; D015127:9,10-Dimethyl-1,2-benzanthracene